Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RSIP Neph is an Israel-based healthcare technology company within the RSIP Vision group focused on AI-enabled intraoperative guidance for urologic surgery. The company develops computer-vision and image-fusion software that combines preoperative CT, intraoperative ultrasound, and robotic stereo camera data to provide a real-time 3D overlay during partial nephrectomy procedures. Its lead solution is intended to help surgeons localize renal tumors and critical anatomical structures that are not directly visible during surgery, potentially improving precision and kidney-sparing outcomes. RSIP Neph appears to operate as a private, active subsidiary or affiliated company of RSIP Vision rather than as an independent drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RSIP Neph.